查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827384

医疗图像市场按模式、组件、应用、最终用户、解剖结构、部署模式和分销管道划分 - 全球预测 2025-2032

Medical Imaging Market by Modality, Component, Application, End User, Anatomy, Deployment Mode, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，医疗图像市场规模将成长至 1,880.7 亿美元，复合年增长率为 15.06%。

主要市场统计数据
基准年2024年 612.2亿美元
预计2025年 704.6亿美元
预测年份：2032年 1880.7亿美元
复合年增长率（%） 15.06%

不断发展的医学影像生态系统的简明框架，将模式创新、临床需求和业务需求与策略决策连结起来

医疗图像影像领域正处于快速技术创新、临床路径演变和医疗保健领域营运压力不断增加的交汇点。影像撷取、处理演算法和资讯学的进步正在扩展诊断能力，同时也提高了对互通性、资料安全性和工作流程效率的期望。同时，医疗系统对改善疗效和控製成本的追求，推动了对具有临床价值且能够无缝整合到更广泛的数位医疗生态系统的影像解决方案的需求。

在此背景下，从製造商到医院采购团队的相关人员正在重新调整投资优先顺序。供应商正在从单一产品策略转向软体驱动的平台和以服务为中心的模式，以支援生命週期价值和经常性收益。临床医生越来越依赖多模态影像来指南诊断和治疗，这使得特定模态的优势和跨模态整合的重要性日益凸显。因此，决策者不仅要考虑技术性能，还要考虑供应链的弹性、法规遵循以及采用先进影像处理工具对员工的影响。

以下章节总结了模态创新、组件生态系统、特定应用要求、最终用户动态、解剖重点领域、部署偏好和分销方法如何塑造整个医疗图像价值链中组织的策略机会和营运风险。

不断发展的模式、人工智慧软体、整合服务和混合分销模式如何重新定义竞争优势和临床采用动态

关键的颠覆性力量正在重塑影像技术的开发、部署和消费方式，这些转变要求製造商、供应商和支付者积极适应。人工智慧和先进的影像分析技术正在加速诊断吞吐量并增强临床解读，从而改变人们对本地和云端部署的软体和资料管理的期望。同时，硬体技术的进步也不断提升解析度和功能洞察力，从锥状射束CT、PET-CT混合扫描和光谱成像等电脑断层扫描技术的进步，到磁振造影和不断扩展的光学成像模式。

同时，核子医学影像，包括正子断层扫描和单光子放射电脑断层扫描 (SEM)，在代谢和分子评估中保持着重要性，推动着专门的临床通讯协定。超音波和 X 光对于即时诊断和常规诊断仍然至关重要，促使製造商投资于便携性和用户友好介面。组件生态系统正在转向提供可衡量价值的整合产品：硬体、软体和安装、维护和有针对性的培训等服务。此外，将直接销售与经销商和线上零售商）结合的分销策略正在优化覆盖范围和售后支援。从医院和影像中心到诊所和门诊手术中心的最终用户都需要弹性价格设定和部署选项。因此，公司必须制定将模态优势与心臟病学、肿瘤学和神经病学等应用领域相结合的策略；考虑从心血管到儿科成像的解剖重点；并平衡云分析与内部控制以实现临床、安全和运营目标。

评估新的关税政策将如何造成供应链复杂性、推动区域製造业转变以及改变耐用成像技术的采购重点

2025年关税和贸易措施的实施将对整个医疗图像供应链产生连锁反应，影响采购选择、采购週期和供应商关係。先前依赖跨境进口零件和成品的供应商正面临投入成本上升和前置作业时间延长的问题，促使客户和製造商重新评估筹资策略。为此，一些製造商加快了区域製造和组装，以减轻关税的影响；而另一些製造商则重新协商了供应商合约或寻求其他物流路线，以维持交货时间和利润结构。

因此，医疗系统和影像服务提供者正在重新评估其资本采购优先顺序和服务合同，优先考虑总体拥有成本和长期可维护性，而非短期降价。关税也引发了关于供应商多元化的讨论，采购团队正在探索多源采购方案，以降低集中度风险。此外，与跨境贸易相关的监管合规性和文件要求增加了行政管理的复杂性，并影响了安装和整合服务的前置作业时间。重要的是，这些发展趋势凸显了售后服务和本地支援的策略重要性。服务提供者高度重视可靠的维护、快速的备件供应以及供应商的应对力，以维持临床运作。

展望未来，贸易政策的累积影响正推动相关人员投资于供应链透明度、情境规划以及明确应对关税意外事件的合约条款。同时，製造商正在评估产品重新设计和模组化方法，以实现高价值部件的本地化，并减轻关税的影响，从而在保持临床性能和安全标准的同时保持竞争力。

从细分观点揭示了医疗模式能力、软体和服务生态系统以及实施偏好如何相互作用，从而决定临床和商业性的成功

检验细分市场的动态变化，可以发现不同设备、组件、应用、最终用户、解剖重点领域、部署模式和分销管道之间存在的差异化商业机会和挑战。包括锥状射束CT、PET-CT 和能谱 CT 在内的电脑断层扫描 (CT) 因其速度快、多能量成像清晰，诊断准确，持续吸引投资；而磁共振系统则因其软组织对比度高、序列先进，有助于製定治疗决策，推动需求增长；核医学成像设备在分子诊断中发挥着关键作用，尤其在肿瘤学和超音波断层扫描领域，发射单极扫描 (PEP) 和单发射断层扫描 (SEP)尤为重要；而光学成像和超音波诊断的应用范围正在拓展，涵盖术中引导和照护现场诊断。 X 光透视系统在急诊医学和常规护理等所有环境中都发挥着重要作用，数位化升级可改善工作流程和影像品质。

从组件角度来看，硬体仍然是成像性能的基础，但软体和服务正日益推动差异化。包含安装和整合、强大的维护和支援以及以临床医生为中心的培训和教育在内的服务包，能够加快临床应用速度并延长正常执行时间。心臟病学和肿瘤学需要高解析度、高度可重复的通讯协定和高级分析，而产科、整形外科和小儿科强调患者舒适度、剂量优化和量身定制的工作流程解决方案。医院和诊断成像中心等最终用户优先考虑扩充性、认证支援和全面的服务合同，而诊所和门诊手术中心通常重视紧凑的外形规格、经济高效的部署模型和简化的维护。

从心血管和脑部影像到乳房和脊柱，解剖学重点领域决定了设备规格、影像通讯协定和报告工具。云端或本地部署的选择取决于资料管治、延迟要求和组织的IT策略，而将直销与经销商、经销商和线上零售商等间接通路结合的分销方式则会影响市场覆盖范围和售后响应能力。这些细分洞察相结合，揭示了成功的策略需要整合针对特定模态的创新、软体支援的工作流程以及针对临床应用和护理环境的独特需求而定制的服务主导支援。

基础设施、报销、监管方式和製造能力的区域模式将决定差异化的采用路径和打入市场策略

区域动态揭示了基础设施成熟度、报销环境、法律规范和製造布局如何影响采用轨迹和战略重点。在美洲，资本投资能力、先进的医院网路和成熟的监管途径正在推动高端医疗设备及分析主导解决方案的快速普及，同时支持强大的售后模式。过渡性资金筹措机制和私营部门的创新正在促进伙伴关係，从而加速新兴影像技术的临床整合。

在欧洲、中东和非洲，多元化的医疗保健系统和多样化的报销方式正在形成独特的需求模式。一些市场优先考虑经济高效的可携式成像解决方案以扩大诊断范围，而其他市场则强调高精度成像模式与先进数据管理相结合，以支援复杂的临床路径。监管协调工作和区域合作影响跨境采购和供应链规划。同时，亚太地区都市区地区正在采用先进技术，而医疗资源匮乏地区对可扩展、可携式远端成像的需求也不断增长。快速扩张的医院基础设施、不断增长的本地製造能力以及政府对医疗技术的策略性投资，正在推动全部区域供应商策略和伙伴关係关係的动态发展。

鑑于这些地区差异，供应商和提供者必须根据当地的临床需求、监管要求和采购惯例产品系列、服务产品和销售模式，并利用製造地、远端医疗网路和官民合作关係关係等当地优势来优化存取和营运弹性。

领先公司如何结合收购、人工智慧伙伴关係、社区服务和灵活分销来建立有弹性的投资组合併扩大临床覆盖范围

产品创新、策略伙伴关係、售后服务以及对软体和数据能力的定向投资正在塑造医疗图像的竞争格局。领先的公司正在透过收购、与人工智慧专家合作以及与临床研究中心合作来扩展其产品组合，以检验新的应用并加快监管核准。这些努力旨在创建一个整合的生态系统，将模态硬体、分析主导的软体和全面的服务相结合，以减少部署阻力并提升生命週期价值。

同时，专注于可携式超音波、频谱CT 增强和云端原生影像管理等利基领域的专业供应商的出现，迫使大型现有企业采用灵活的伙伴关係模式。差异化的售后服务，包括快速安装、预防性保养、备件物流和临床医生培训，可以成为竞争优势，尤其是在供应链不确定性放大本地化支援价值的情况下。此外，结合与大型医疗系统的直接接触以及将覆盖范围扩大到门诊和诊所的间接管道的分销策略，使公司能够优化其覆盖范围和应对力。随着相关人员优先考虑互通性和开放式架构，投资于基于标准的整合和开发者生态系统的公司将处于有利地位，能够获取长期价值并扩展到相邻的数位健康领域。

实用、多管齐下的策略方案，将产品模组化、软体和服务、供应链弹性以及区域上市执行结合起来，以获得永续优势

产业领导者必须采取务实、多层面的策略，抓住机会，同时降低营运和政策风险。首先，优先考虑产品模组化和在地化设计，降低关税主导的成本波动风险，并实现在各地区的快速组装和配置。其次，增加对软体和服务的投资，提升硬体的价值——尤其是人工智慧分析、云端或混合数据管理以及针对临床医生的培训——以创造经常性收益流并提高员工留存率。第三，透过多方采购、关键零件的策略性库存缓衝以及应对贸易突发事件的合约保护措施，提高供应链透明度。

同时，我们根据区域差异定制市场进入策略，将定价和销售模式与当地采购惯例和最终用户能力相结合，同时确保强大的售后市场影响力，确保运作和零件供应。我们与系统整合商、临床网路和技术供应商建立策略伙伴关係，以增强互通性并加速临床检验。最后，我们将资料管治、网路安全和法规遵循融入产品开发和服务交付中，以满足医疗保健提供者的期望并加速采购决策。这些措施的结合使组织能够保持竞争力，支持临床应用，并适应快速发展的政策和技术环境。

证据主导的调查方法结合了专家访谈、系统性文献分析、情境评估和交叉检验，以确保严谨且可行的见解

调查方法整合了原厂药和二手资料，以建立强有力的依证，并透过相关人员三​​角测量检验主题研究结果。原厂药物包括与临床负责人、采购专业人员、影像技术人员以及製造商和经销商高管进行结构化访谈和专家咨询，从而获得关于营运挑战、应用驱动因素和服务期望的第一手见解。二手资料研究则包括对同侪审查文献、监管指南、专利申请、公司揭露资讯和技术白皮书的系统性回顾，以绘製技术趋势和过往研发成果。

基于情境的分析也探讨了贸易措施等政策变化对供应链和采购行为的影响。为确保严谨性，研究结果由独立专家小组进行交叉检验，并与已知的监管和临床标准进行比对。研究的局限性包括不同地区公开的营运指标存在差异，以及人工智慧和软体法规的不断演变，因此需要谨慎地结合具体情况，并对短期影响进行保守的解读。访谈通讯协定和资料处理均遵循伦理考量，以保护隐私并确保分析的客观性。

简洁的综合，将技术进步、服务主导的差异化和供应链弹性结合起来，作为持续采用和价值交付的核心决定因素

总体而言，医疗图像产业正在经历一场持续的变革时期，其驱动力来自硬体、分析和服务交付模式的不断发展，以及政策和采购动态的转变。特定设备领域的创新不断扩大诊断和治疗能力，但关键的差异化因素日益体现在软体整合、售后服务和供应链的适应性。不断变化的贸易政策正在提昇在地化、模组化设计和多元化采购的重要性，迫使相关人员重新评估其采购框架，并优先考虑全生命週期价值。

展望未来，成功的组织将在核心影像处理能力的投资与战略性软体能力、以临床医生为中心的培训计划以及能够应对本地差异的弹性分销和服务网络之间取得平衡。透过使产品设计、商业模式和营运流程与法规环境的实际情况、实施偏好和最终用户需求相协调，供应商和提供者能够在保持财务和营运稳定的同时更好地支援临床结果。最终，有意识地关注互通性、卓越服务和风险管理的供应链，将支持医疗机构持续采用和创新。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 整合人工智慧演算法用于放射学的自动诊断和工作流程优化
  • 推出可在患者床边进行即时诊断的可携式照护现场影像设备
  • 扩展云端基础的PACS 解决方案，实现远端存取和影像检查的协作解释
  • 透过开发结合 PET、MRI 和 CT 的混合多模态影像诊断系统进行全面的疾病评估
  • 实施先进的低剂量 CT通讯协定，在保持影像品质的同时最大限度地减少辐射暴露
  • 整合机器学习模型，用于肿瘤成像的预测分析和个人化治疗计划
  • 扩增实境和全像视觉化工具的出现有助于手术影像和训练
  • 加强法规和标准化工作，确保医疗图像资料安全和互通性

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第 8 章医疗图像市场（按模式）

  • 电脑断层扫描
    • 锥状射束CT
    • PET-CT
    • 频谱CT
  • 磁振造影
  • 核子造影
    • 正子断层扫描
    • 单光子发射电脑断层扫描
  • 光学成像
  • 超音波
  • X射线

第九章医疗图像市场（按组件）

  • 硬体
  • 服务
    • 安装和集成
    • 维护和支援
    • 培训和教育
  • 软体

第 10 章医疗图像市场（按应用）

  • 心臟病学
  • 胃肠病学
  • 神经病学
  • 妇产科
  • 肿瘤学
  • 整形外科
  • 泌尿系统

第 11 章医疗图像市场（按最终用户）

  • 门诊手术中心
  • 诊所
  • 诊断影像中心
  • 医院

第 12 章医疗图像市场（按解剖学）

  • 腹部
  • 脑
  • 胸部
  • 心血管系统
  • 肌肉骨骼
  • 孩子们
  • 脊椎

第十三章医疗图像市场（依部署模式）

  • 云
  • 本地部署

第十四章医疗图像市场（按分销管道）

  • 直销
  • 间接销售
    • 经销商
    • 经销商
    • 线上零售商

第十五章医疗图像市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章医疗图像市场：依类别

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章 各国医疗图像市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Siemens Healthineers AG
    • General Electric Company
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • Fujifilm Holdings Corporation
    • Hitachi, Ltd.
    • Shimadzu Corporation
    • Carestream Health, Inc.
    • Samsung Medison Co., Ltd.
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Product Code: MRR-434CCDA04E90

The Medical Imaging Market is projected to grow by USD 188.07 billion at a CAGR of 15.06% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 61.22 billion
Estimated Year [2025] USD 70.46 billion
Forecast Year [2032] USD 188.07 billion
CAGR (%) 15.06%

A concise framing of the evolving medical imaging ecosystem that links modality innovation, clinical demand, and operational imperatives to strategic decision-making

The medical imaging landscape sits at the intersection of rapid technological innovation, evolving clinical pathways, and intensifying operational pressures across care settings. Advances in image acquisition, processing algorithms, and informatics have expanded diagnostic capabilities while simultaneously raising expectations for interoperability, data security, and workflow efficiency. Meanwhile, health systems pursue improved outcomes and cost management, which amplifies demand for imaging solutions that demonstrate clinical value and seamless integration into broader digital health ecosystems.

Against this backdrop, stakeholders from manufacturers to hospital procurement teams are reassessing investment priorities. Vendors are moving beyond single-product strategies toward software-enabled platforms and service-centric models that support lifecycle value and recurring revenue. Clinicians increasingly rely on multimodal imaging to guide diagnosis and therapy, which elevates the importance of modality-specific strengths and integration across modalities. Consequently, decision-makers must consider not only technology performance but also supply chain resilience, regulatory compliance, and the workforce implications of adopting advanced imaging tools.

In the following sections, the report synthesizes how modality innovation, component ecosystems, application-specific requirements, end-user dynamics, anatomical focus areas, deployment preferences, and distribution approaches collectively shape strategic opportunities and operational risks for organizations across the medical imaging value chain.

How modality advancements, AI-enabled software, integrated services, and hybrid distribution models are collectively redefining competitive advantage and clinical adoption dynamics

Major disruptive forces are reshaping how imaging technologies are developed, deployed, and consumed, and these shifts demand proactive adaptation from manufacturers, providers, and payers alike. Artificial intelligence and advanced image analytics are accelerating diagnostic throughput and augmenting clinical interpretation, which in turn changes expectations for software and data management across on-premise and cloud deployment modes. At the same time, hardware evolution-spanning computed tomography with advances such as cone beam CT, PET-CT hybrids and spectral imaging, to magnetic resonance and expanding optical imaging modalities-continues to enhance resolution and functional insights.

Simultaneously, nuclear imaging retains importance for metabolic and molecular assessments, with positron emission tomography and single photon emission computed tomography driving specialized clinical protocols. Ultrasound and X-ray remain indispensable for point-of-care and routine diagnostics, prompting manufacturers to invest in portability and user-friendly interfaces. Component ecosystems are shifting toward integrated offerings where hardware, software, and services such as installation, maintenance and targeted training converge to deliver measurable value. Furthermore, distribution strategies that blend direct sales with indirect channels including dealers, distributors and online retailers are optimizing reach and aftermarket support, while end users from hospitals and diagnostic imaging centers to clinics and ambulatory surgical centers demand flexible pricing and deployment options. As a result, organizations must craft strategies that align modality strengths with application areas such as cardiology, oncology and neurology, account for anatomical focus from cardiovascular to pediatric imaging, and balance cloud-enabled analytics with on-premise control to meet clinical, security and operational objectives.

Assessing how new tariff policies introduce supply chain complexity, prompt regional manufacturing shifts, and alter procurement priorities for durable imaging technologies

The introduction of tariffs and trade measures in 2025 has reverberated across the medical imaging supply chain, influencing sourcing choices, procurement cycles, and supplier relationships. Suppliers that previously relied on cross-border components and finished equipment imports have faced increased input costs and longer lead times, prompting both customers and manufacturers to reevaluate their procurement strategies. In response, some manufacturers have accelerated regional manufacturing or assembly to mitigate tariff exposure, while others have renegotiated supplier contracts or pursued alternative logistics pathways to preserve delivery schedules and margin structures.

Consequently, health systems and imaging providers have reassessed capital procurement priorities and service agreements, often emphasizing total cost of ownership and long-term serviceability over short-term price reductions. The tariffs have also intensified discussions around vendor diversification, with procurement teams seeking multi-sourced options to reduce concentration risk. Moreover, regulatory compliance and documentation requirements associated with cross-border trade have added administrative complexity, influencing lead times for installation and integration services. Importantly, these dynamics have strengthened the strategic significance of aftermarket services and localized support, as providers place higher value on reliable maintenance, rapid spare parts availability, and vendor responsiveness to sustain clinical operations.

Looking ahead, the cumulative impact of trade policy is encouraging stakeholders to invest in supply chain transparency, scenario planning, and contractual terms that explicitly address tariff contingencies. In parallel, manufacturers are evaluating product redesign and modularization approaches to localize higher-value components and reduce tariff exposure, thereby preserving competitiveness while maintaining clinical performance and safety standards.

Segment-level perspectives that reveal how modality capabilities, software and service ecosystems, and deployment preferences interact to determine clinical and commercial success

Examining segment-level dynamics reveals differentiated opportunities and operational challenges across modalities, components, applications, end users, anatomical focus areas, deployment modes, and distribution channels. Computed tomography, including cone beam CT, PET-CT and spectral CT variants, continues to attract investment where speed and multi-energy imaging deliver diagnostic clarity, while magnetic resonance systems drive demand where soft tissue contrast and advanced sequences inform therapeutic decision-making. Nuclear imaging maintains a crucial role for molecular diagnostics via positron emission tomography and single photon emission computed tomography, especially in oncology and neurology, whereas optical imaging and ultrasound extend diagnostic reach to intraoperative guidance and point-of-care assessment. X-ray systems remain foundational across emergency and routine care settings, benefitting from digital upgrades that enhance workflow and image quality.

From a component perspective, hardware remains fundamental to imaging performance, but software and services increasingly determine differentiation. Service bundles that include installation and integration, robust maintenance and support, and clinician-focused training and education enable faster clinical adoption and higher uptime. Application-driven requirements steer modality selection: cardiology and oncology demand high-resolution, reproducible protocols and advanced analytics, while obstetrics, orthopedics and pediatrics emphasize patient comfort, dose optimization and tailored workflow solutions. End users such as hospitals and diagnostic imaging centers prioritize scalability, accreditation support and comprehensive service agreements, whereas clinics and ambulatory surgical centers often value compact form factors, cost-effective deployment models and simplified maintenance.

Anatomical focus areas-from cardiovascular and brain imaging to breast and spine diagnostics-shape device specifications, imaging protocols and reporting tools. Deployment mode choices between cloud and on-premise arrangements hinge on data governance, latency requirements and institutional IT strategies, and distribution approaches that combine direct sales with indirect channels like dealers, distributors and online retailers influence market reach and aftermarket responsiveness. Collectively, these segmentation insights underscore that winning strategies integrate modality-specific innovation, software-enabled workflows and service-driven support tailored to the unique needs of clinical applications and care settings.

Regional patterns in infrastructure, reimbursement, regulatory approaches, and manufacturing capacity that determine differentiated adoption pathways and go-to-market strategies

Regional dynamics underscore how infrastructure maturity, reimbursement environments, regulatory frameworks, and manufacturing footprints influence adoption trajectories and strategic priorities. In the Americas, capital investment capacity, advanced hospital networks, and established regulatory pathways have fostered rapid uptake of high-end modalities and analytics-driven solutions, while also supporting robust aftermarket service models. Transitional funding mechanisms and private sector innovation encourage partnerships that accelerate clinical integration of emerging imaging technologies.

Across Europe, the Middle East and Africa, heterogeneous healthcare systems and varied reimbursement approaches create differentiated demand patterns; some markets prioritize cost-effective, portable imaging solutions to extend diagnostic reach, while others emphasize high-acuity modalities paired with sophisticated data management to support complex clinical pathways. Regulatory harmonization efforts and regional collaborations influence cross-border procurement and supply chain planning. Meanwhile, Asia-Pacific exhibits a mix of advanced technology adoption in urban centers and growing demand for scalable, portable, and tele-enabled imaging in underserved areas. Rapidly expanding hospital infrastructure, growing local manufacturing capabilities and strategic government investments in health technology drive dynamic vendor strategies and partnerships across the region.

Taken together, these regional distinctions require vendors and providers to calibrate product portfolios, service offerings, and distribution models to local clinical needs, regulatory requirements and procurement practices, while leveraging regional strengths such as manufacturing hubs, telehealth networks, and public-private partnerships to optimize access and operational resilience.

How leading firms are combining acquisitions, AI partnerships, localized services, and flexible distribution to build resilient portfolios and expand clinical reach

Competitive trajectories within the medical imaging landscape are shaped by a mix of product innovation, strategic partnerships, aftermarket services, and targeted investments in software and data capabilities. Leading firms are broadening portfolios through acquisitions, alliances with AI specialists and collaborations with clinical research centers to validate new applications and accelerate regulatory approvals. These efforts aim to create integrated ecosystems that combine modality hardware, analytics-driven software, and comprehensive service offerings that reduce adoption friction and enhance lifecycle value.

At the same time, an emergent cohort of specialized vendors focuses on niche segments such as portable ultrasound, spectral CT enhancements or cloud-native image management, compelling larger incumbents to adopt flexible partnership models. Aftermarket service differentiation-encompassing rapid installation, preventative maintenance, spare parts logistics and clinician training-has become a competitive lever, particularly when supply chain uncertainties amplify the value of localized support. Moreover, distribution strategies that incorporate both direct engagement with large health systems and indirect channels to extend reach into ambulatory care and clinics allow companies to optimize coverage and responsiveness. As stakeholders prioritize interoperability and open architectures, companies that invest in standards-based integration and developer ecosystems are better positioned to capture long-term value and expand into adjacent digital health domains.

A practical, multi-pronged strategic playbook that aligns product modularity, software and services, supply chain resilience, and regional go-to-market execution for sustained advantage

Industry leaders must adopt a pragmatic, multi-dimensional playbook to capitalize on opportunities while mitigating operational and policy risks. First, prioritize product modularity and design for localization to reduce exposure to tariff-driven cost volatility and enable faster regional assembly or configuration. Second, deepen investments in software and services that augment hardware value-particularly AI-enabled analytics, cloud or hybrid data management and clinician-focused training-to create recurring revenue streams and improve retention. Third, strengthen supply chain transparency through multi-sourcing, strategic inventory buffers for critical components, and contractual protections that address trade contingencies.

In parallel, align go-to-market approaches with regional nuances by tailoring pricing and distribution models to local procurement practices and end-user capabilities, while ensuring robust aftermarket arrangements that guarantee uptime and parts availability. Foster strategic partnerships with systems integrators, clinical networks and technology vendors to enhance interoperability and accelerate clinical validation. Finally, embed data governance, cybersecurity and regulatory readiness into product development and service delivery to meet institutional expectations and expedite procurement decisions. Taken together, these actions enable organizations to sustain competitiveness, support clinical adoption, and adapt to a rapidly evolving policy and technology environment.

An evidence-driven methodology combining expert interviews, systematic literature analysis, scenario assessment, and cross-validation to ensure rigorous and actionable insights

The research approach integrated primary and secondary methods to generate a robust evidence base and validate thematic findings through stakeholder triangulation. Primary research comprised structured interviews and expert consultations with clinical leaders, procurement specialists, imaging technologists, and senior executives from manufacturers and distributors, enabling direct insight into operational challenges, adoption drivers, and service expectations. Secondary research involved systematic review of peer-reviewed literature, regulatory guidance, patent filings, company disclosures and technical whitepapers to map technology trends and historical developments.

Data synthesis employed qualitative coding to identify recurring themes and quantitative aggregation where appropriate to describe adoption patterns and service models, while scenario-based analysis explored the implications of policy shifts, such as trade measures, on supply chains and procurement behavior. To ensure rigor, findings were cross-validated with independent expert panels and reconciled against known regulatory and clinical standards. Limitations included variability in publicly available operational metrics across regions and the evolving nature of AI and software regulations, which necessitated careful contextualization and conservative interpretation of near-term implications. Ethical considerations guided interview protocols and data handling to protect confidentiality and ensure objective analysis.

A concise synthesis that connects technology progress, service-driven differentiation, and supply chain resilience as the core determinants of sustained adoption and value delivery

In synthesis, the medical imaging sector is undergoing a sustained period of transformation driven by converging advances in hardware, analytics, and service delivery models alongside shifting policy and procurement dynamics. Modality-specific innovation continues to expand diagnostic and therapeutic capabilities, but the decisive differentiators increasingly reside in software integration, aftermarket services and supply chain adaptability. Trade policy developments have heightened the importance of localization, modular design and diversified sourcing, prompting stakeholders to reassess procurement frameworks and prioritize total lifecycle value.

Going forward, successful organizations will balance investment in core imaging performance with strategic software capabilities, clinician-centered training programs, and resilient distribution and service networks that accommodate regional nuances. By aligning product design, commercial models and operational processes with the realities of regulatory environments, deployment preferences and end-user needs, vendors and providers can better support clinical outcomes while preserving financial and operational stability. Ultimately, a deliberate focus on interoperability, service excellence and risk-managed supply chains will underpin sustained adoption and innovation across care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence algorithms for automated diagnosis and workflow optimization in radiology
  • 5.2. Adoption of portable and point-of-care imaging devices enabling real-time diagnostics at patient bedside
  • 5.3. Expansion of cloud-based PACS solutions for remote access and collaborative interpretation of imaging studies
  • 5.4. Development of hybrid multimodal imaging systems combining PET MRI and CT for comprehensive disease evaluation
  • 5.5. Implementation of advanced low-dose CT protocols to minimize radiation exposure while maintaining image quality
  • 5.6. Integration of machine learning models for predictive analysis and personalized treatment planning in oncology imaging
  • 5.7. Emergence of augmented reality and holographic visualization tools to assist in surgical imaging and training
  • 5.8. Increasing regulatory focus and standardization efforts to ensure data security and interoperability in medical imaging

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Imaging Market, by Modality

  • 8.1. Computed Tomography
    • 8.1.1. Cone Beam CT
    • 8.1.2. PET-CT
    • 8.1.3. Spectral CT
  • 8.2. Magnetic Resonance Imaging
  • 8.3. Nuclear Imaging
    • 8.3.1. Positron Emission Tomography
    • 8.3.2. Single Photon Emission Computed Tomography
  • 8.4. Optical Imaging
  • 8.5. Ultrasound
  • 8.6. X Ray

9. Medical Imaging Market, by Component

  • 9.1. Hardware
  • 9.2. Services
    • 9.2.1. Installation & Integration
    • 9.2.2. Maintenance & Support
    • 9.2.3. Training & Education
  • 9.3. Software

10. Medical Imaging Market, by Application

  • 10.1. Cardiology
  • 10.2. Gastroenterology
  • 10.3. Neurology
  • 10.4. Obstetrics & Gynecology
  • 10.5. Oncology
  • 10.6. Orthopedics
  • 10.7. Urology

11. Medical Imaging Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Diagnostic Imaging Centers
  • 11.4. Hospitals

12. Medical Imaging Market, by Anatomy

  • 12.1. Abdominal
  • 12.2. Brain
  • 12.3. Breast
  • 12.4. Cardiovascular
  • 12.5. Musculoskeletal
  • 12.6. Pediatrics
  • 12.7. Spine

13. Medical Imaging Market, by Deployment Mode

  • 13.1. Cloud
  • 13.2. On Premise

14. Medical Imaging Market, by Distribution Channel

  • 14.1. Direct Sales
  • 14.2. Indirect Sales
    • 14.2.1. Dealers
    • 14.2.2. Distributors
    • 14.2.3. Online Retailers

15. Medical Imaging Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Medical Imaging Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Medical Imaging Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Siemens Healthineers AG
    • 18.3.2. General Electric Company
    • 18.3.3. Koninklijke Philips N.V.
    • 18.3.4. Canon Medical Systems Corporation
    • 18.3.5. Fujifilm Holdings Corporation
    • 18.3.6. Hitachi, Ltd.
    • 18.3.7. Shimadzu Corporation
    • 18.3.8. Carestream Health, Inc.
    • 18.3.9. Samsung Medison Co., Ltd.
    • 18.3.10. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL IMAGING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL MEDICAL IMAGING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL MEDICAL IMAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS MEDICAL IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. MEDICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. MEDICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MEDICAL IMAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MEDICAL IMAGING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL IMAGING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CONE BEAM CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CONE BEAM CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CONE BEAM CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CONE BEAM CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CONE BEAM CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CONE BEAM CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PET-CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PET-CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PET-CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PET-CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PET-CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PET-CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPECTRAL CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPECTRAL CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPECTRAL CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPECTRAL CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPECTRAL CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPECTRAL CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL IMAGING MARKET SIZE, BY X RAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL IMAGING MARKET SIZE, BY X RAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL IMAGING MARKET SIZE, BY X RAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL IMAGING MARKET SIZE, BY X RAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL IMAGING MARKET SIZE, BY X RAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL IMAGING MARKET SIZE, BY X RAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HARDWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HARDWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INSTALLATION & INTEGRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INSTALLATION & INTEGRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INSTALLATION & INTEGRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INSTALLATION & INTEGRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INSTALLATION & INTEGRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INSTALLATION & INTEGRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEDICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL MEDICAL IMAGING MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL MEDICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL MEDICAL IMAGING MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL MEDICAL IMAGING MARKET SIZE, BY UROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL MEDICAL IMAGING MARKET SIZE, BY UROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL MEDICAL IMAGING MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL MEDICAL IMAGING MARKET SIZE, BY UROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL MEDICAL IMAGING MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL MEDICAL IMAGING MARKET SIZE, BY UROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL MEDICAL IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL MEDICAL IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL MEDICAL IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL MEDICAL IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL MEDICAL IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL MEDICAL IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL MEDICAL IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL MEDICAL IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ABDOMINAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ABDOMINAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ABDOMINAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ABDOMINAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ABDOMINAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ABDOMINAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BRAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BRAIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BRAIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BRAIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BRAIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BRAIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BREAST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BREAST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BREAST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BREAST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BREAST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL MEDICAL IMAGING MARKET SIZE, BY BREAST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL MEDICAL IMAGING MARKET SIZE, BY MUSCULOSKELETAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PEDIATRICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL MEDICAL IMAGING MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL MEDICAL IMAGING MARKET SIZE, BY SPINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLOUD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLOUD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLOUD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLOUD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL MEDICAL IMAGING MARKET SIZE, BY CLOUD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ON PREMISE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ON PREMISE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ON PREMISE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INDIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INDIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INDIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INDIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INDIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INDIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL MEDICAL IMAGING MARKET SIZE, BY INDIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DEALERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DEALERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DEALERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DEALERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DEALERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DEALERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONLINE RETAILERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONLINE RETAILERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONLINE RETAILERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONLINE RETAILERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONLINE RETAILERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL MEDICAL IMAGING MARKET SIZE, BY ONLINE RETAILERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL MEDICAL IMAGING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL MEDICAL IMAGING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS MEDICAL IMAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS MEDICAL IMAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2025-2032 (USD MILLION)
  • TABLE 289. AMERICAS MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 290. AMERICAS MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 291. AMERICAS MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 292. AMERICAS MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 293. AMERICAS MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. AMERICAS MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 295. AMERICAS MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. AMERICAS MEDICAL IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. AMERICAS MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2024 (USD MILLION)
  • TABLE 298. AMERICAS MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2025-2032 (USD MILLION)
  • TABLE 299. AMERICAS MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 300. AMERICAS MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 301. AMERICAS MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 302. AMERICAS MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 303. AMERICAS MEDICAL IMAGING MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 304. AMERICAS MEDICAL IMAGING MARKET SIZE, BY INDIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 305. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 308. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 309. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 310. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2025-2032 (USD MILLION)
  • TABLE 311. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2024 (USD MILLION)
  • TABLE 312. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2025-2032 (USD MILLION)
  • TABLE 313. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 314. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 315. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 316. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 317. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 318. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 319. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 320. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 321. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2018-2024 (USD MILLION)
  • TABLE 322. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY ANATOMY, 2025-2032 (USD MILLION)
  • TABLE 323. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 324. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 325. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 326. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 327. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 328. NORTH AMERICA MEDICAL IMAGING MARKET SIZE, BY INDIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 329. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 330. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 331. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 332. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 333. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 334. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2025-2032 (USD MILLION)
  • TABLE 335. LATIN AMERICA MEDICAL IMAGING MARKET SIZE, BY NUCLEAR IMAGING, 2018-2024 (USD MILLION)
  • TABLE 336. LATIN AMERICA MEDICAL IMAGING MARKET SIZE,